Clinical trial
Safety & Efficacy of NV1020 in Colorectal Cancer Metastatic to the Liver
NCT00149396 · MediGene, Industry · Completed
Key facts
| NCT number | NCT00149396 |
|---|---|
| Title | Safety & Efficacy of NV1020 in Colorectal Cancer Metastatic to the Liver |
| Official title | A Phase I/II, Open-label Study to Evaluate the Safety and Anti-tumor Effects of NV1020 Administered Repeatedly Via Hepatic Artery Infusion Prior to Second-line Chemotherapy, in Patients With Colorectal Adenocarcinoma Metastatic to the Liver |
| Lead sponsor | MediGene, Industry |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Colorectal Cancer, Liver Neoplasms |
| Intervention type | Drug |
| Interventions | NV1020 |
| Enrollment | 32 |
| Start date | Jul 1, 2004 |
| Primary completion | Oct 1, 2008 |
| Completion | Dec 1, 2008 |
| First posted | Sep 8, 2005 |
| Last update posted | Apr 24, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: